Lancet Reg Health West Pac 润色咨询

The Lancet Regional Health – Western Pacific

出版年份:暂无数据 年文章数:256 投稿命中率: 开通期刊会员,数据随心看

出版周期:暂无数据 自引率:暂无数据 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2170791, encodeId=729821e0791d1, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:心血管<br>经验分享:还没投,不知道, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24268459349, createdName=ms9000001322752373, createdTime=Fri Nov 24 17:12:52 CST 2023, time=2023-11-24, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2141847, encodeId=dbd8214184eb2, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:妇产科学;生育健康<br>经验分享:4.26 投稿<br>4.29 under review<br>中间状态变为 with editor, under review, required reviews completed,under review<br>5.28 required reviews completed,目前该持续近两周<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96ca8289510, createdName=ms8000000261515096, createdTime=Fri Jun 09 10:50:18 CST 2023, time=2023-06-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2100279, encodeId=80a121002e986, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:送审5-6位专家,意见给的都挺多,挺中肯。editor处理速度挺快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b5e3064566, createdName=3120102952, createdTime=Sun Nov 13 16:11:14 CST 2022, time=2022-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1110606, encodeId=fd2f11106067e, content=RUNNINGTITLE和TITLE的区别?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=491, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Mon Dec 27 14:52:54 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226206, encodeId=5cd51226206ca, content=Plagiarism check 投稿时这个选项是必须要填的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=213, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44d08201428, createdName=ms7000001023316259, createdTime=Mon Jun 13 17:39:32 CST 2022, time=2022-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227148, encodeId=e940122e148b0, content=这个会进sci吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=225, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ac0d5397053, createdName=小月小月, createdTime=Sat Jun 18 07:12:01 CST 2022, time=2022-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226209, encodeId=fa6f12262097f, content=投稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=225, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44d08201428, createdName=ms7000001023316259, createdTime=Mon Jun 13 17:40:14 CST 2022, time=2022-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1110605, encodeId=fc751110605c1, content=RUNINGTITLE是必须的么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=398, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:54 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1073882, encodeId=bff110e388286, content=审稿速度:1.0 | 投稿命中率:25.0 | 版面费用:3500.0<br>偏重的研究方向:大数据;临床<br>经验分享:新刊,目前审稿很快,偏向临床大数据研究, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=495, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59955713944, createdName=ms7000001323288958, createdTime=Thu Nov 25 16:45:11 CST 2021, time=2021-11-25, status=1, ipAttribution=)]
    2023-11-24 ms9000001322752373 来自上海

    审稿速度:1.0 | 投稿命中率:50.0
    偏重的研究方向:心血管
    经验分享:还没投,不知道

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2170791, encodeId=729821e0791d1, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:心血管<br>经验分享:还没投,不知道, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24268459349, createdName=ms9000001322752373, createdTime=Fri Nov 24 17:12:52 CST 2023, time=2023-11-24, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2141847, encodeId=dbd8214184eb2, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:妇产科学;生育健康<br>经验分享:4.26 投稿<br>4.29 under review<br>中间状态变为 with editor, under review, required reviews completed,under review<br>5.28 required reviews completed,目前该持续近两周<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96ca8289510, createdName=ms8000000261515096, createdTime=Fri Jun 09 10:50:18 CST 2023, time=2023-06-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2100279, encodeId=80a121002e986, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:送审5-6位专家,意见给的都挺多,挺中肯。editor处理速度挺快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b5e3064566, createdName=3120102952, createdTime=Sun Nov 13 16:11:14 CST 2022, time=2022-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1110606, encodeId=fd2f11106067e, content=RUNNINGTITLE和TITLE的区别?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=491, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Mon Dec 27 14:52:54 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226206, encodeId=5cd51226206ca, content=Plagiarism check 投稿时这个选项是必须要填的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=213, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44d08201428, createdName=ms7000001023316259, createdTime=Mon Jun 13 17:39:32 CST 2022, time=2022-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227148, encodeId=e940122e148b0, content=这个会进sci吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=225, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ac0d5397053, createdName=小月小月, createdTime=Sat Jun 18 07:12:01 CST 2022, time=2022-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226209, encodeId=fa6f12262097f, content=投稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=225, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44d08201428, createdName=ms7000001023316259, createdTime=Mon Jun 13 17:40:14 CST 2022, time=2022-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1110605, encodeId=fc751110605c1, content=RUNINGTITLE是必须的么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=398, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:54 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1073882, encodeId=bff110e388286, content=审稿速度:1.0 | 投稿命中率:25.0 | 版面费用:3500.0<br>偏重的研究方向:大数据;临床<br>经验分享:新刊,目前审稿很快,偏向临床大数据研究, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=495, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59955713944, createdName=ms7000001323288958, createdTime=Thu Nov 25 16:45:11 CST 2021, time=2021-11-25, status=1, ipAttribution=)]
    2023-06-09 ms8000000261515096 来自北京

    审稿速度:2.0 | 投稿命中率:25.0
    偏重的研究方向:妇产科学;生育健康
    经验分享:4.26 投稿
    4.29 under review
    中间状态变为 with editor, under review, required reviews completed,under review
    5.28 required reviews completed,目前该持续近两周

    2

    展开2条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=2170791, encodeId=729821e0791d1, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:心血管<br>经验分享:还没投,不知道, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24268459349, createdName=ms9000001322752373, createdTime=Fri Nov 24 17:12:52 CST 2023, time=2023-11-24, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2141847, encodeId=dbd8214184eb2, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:妇产科学;生育健康<br>经验分享:4.26 投稿<br>4.29 under review<br>中间状态变为 with editor, under review, required reviews completed,under review<br>5.28 required reviews completed,目前该持续近两周<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96ca8289510, createdName=ms8000000261515096, createdTime=Fri Jun 09 10:50:18 CST 2023, time=2023-06-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2100279, encodeId=80a121002e986, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:送审5-6位专家,意见给的都挺多,挺中肯。editor处理速度挺快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b5e3064566, createdName=3120102952, createdTime=Sun Nov 13 16:11:14 CST 2022, time=2022-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1110606, encodeId=fd2f11106067e, content=RUNNINGTITLE和TITLE的区别?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=491, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Mon Dec 27 14:52:54 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226206, encodeId=5cd51226206ca, content=Plagiarism check 投稿时这个选项是必须要填的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=213, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44d08201428, createdName=ms7000001023316259, createdTime=Mon Jun 13 17:39:32 CST 2022, time=2022-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227148, encodeId=e940122e148b0, content=这个会进sci吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=225, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ac0d5397053, createdName=小月小月, createdTime=Sat Jun 18 07:12:01 CST 2022, time=2022-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226209, encodeId=fa6f12262097f, content=投稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=225, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44d08201428, createdName=ms7000001023316259, createdTime=Mon Jun 13 17:40:14 CST 2022, time=2022-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1110605, encodeId=fc751110605c1, content=RUNINGTITLE是必须的么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=398, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:54 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1073882, encodeId=bff110e388286, content=审稿速度:1.0 | 投稿命中率:25.0 | 版面费用:3500.0<br>偏重的研究方向:大数据;临床<br>经验分享:新刊,目前审稿很快,偏向临床大数据研究, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=495, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59955713944, createdName=ms7000001323288958, createdTime=Thu Nov 25 16:45:11 CST 2021, time=2021-11-25, status=1, ipAttribution=)]
    2022-11-13 3120102952

    审稿速度:1.0 | 投稿命中率:25.0
    经验分享:送审5-6位专家,意见给的都挺多,挺中肯。editor处理速度挺快。

    2

    展开2条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=2170791, encodeId=729821e0791d1, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:心血管<br>经验分享:还没投,不知道, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24268459349, createdName=ms9000001322752373, createdTime=Fri Nov 24 17:12:52 CST 2023, time=2023-11-24, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2141847, encodeId=dbd8214184eb2, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:妇产科学;生育健康<br>经验分享:4.26 投稿<br>4.29 under review<br>中间状态变为 with editor, under review, required reviews completed,under review<br>5.28 required reviews completed,目前该持续近两周<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96ca8289510, createdName=ms8000000261515096, createdTime=Fri Jun 09 10:50:18 CST 2023, time=2023-06-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2100279, encodeId=80a121002e986, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:送审5-6位专家,意见给的都挺多,挺中肯。editor处理速度挺快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b5e3064566, createdName=3120102952, createdTime=Sun Nov 13 16:11:14 CST 2022, time=2022-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1110606, encodeId=fd2f11106067e, content=RUNNINGTITLE和TITLE的区别?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=491, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Mon Dec 27 14:52:54 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226206, encodeId=5cd51226206ca, content=Plagiarism check 投稿时这个选项是必须要填的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=213, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44d08201428, createdName=ms7000001023316259, createdTime=Mon Jun 13 17:39:32 CST 2022, time=2022-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227148, encodeId=e940122e148b0, content=这个会进sci吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=225, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ac0d5397053, createdName=小月小月, createdTime=Sat Jun 18 07:12:01 CST 2022, time=2022-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226209, encodeId=fa6f12262097f, content=投稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=225, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44d08201428, createdName=ms7000001023316259, createdTime=Mon Jun 13 17:40:14 CST 2022, time=2022-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1110605, encodeId=fc751110605c1, content=RUNINGTITLE是必须的么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=398, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:54 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1073882, encodeId=bff110e388286, content=审稿速度:1.0 | 投稿命中率:25.0 | 版面费用:3500.0<br>偏重的研究方向:大数据;临床<br>经验分享:新刊,目前审稿很快,偏向临床大数据研究, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=495, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59955713944, createdName=ms7000001323288958, createdTime=Thu Nov 25 16:45:11 CST 2021, time=2021-11-25, status=1, ipAttribution=)]
    2021-12-27 学医的彭于晏

    RUNNINGTITLE和TITLE的区别?

    2

    展开2条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=2170791, encodeId=729821e0791d1, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:心血管<br>经验分享:还没投,不知道, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24268459349, createdName=ms9000001322752373, createdTime=Fri Nov 24 17:12:52 CST 2023, time=2023-11-24, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2141847, encodeId=dbd8214184eb2, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:妇产科学;生育健康<br>经验分享:4.26 投稿<br>4.29 under review<br>中间状态变为 with editor, under review, required reviews completed,under review<br>5.28 required reviews completed,目前该持续近两周<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96ca8289510, createdName=ms8000000261515096, createdTime=Fri Jun 09 10:50:18 CST 2023, time=2023-06-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2100279, encodeId=80a121002e986, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:送审5-6位专家,意见给的都挺多,挺中肯。editor处理速度挺快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b5e3064566, createdName=3120102952, createdTime=Sun Nov 13 16:11:14 CST 2022, time=2022-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1110606, encodeId=fd2f11106067e, content=RUNNINGTITLE和TITLE的区别?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=491, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Mon Dec 27 14:52:54 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226206, encodeId=5cd51226206ca, content=Plagiarism check 投稿时这个选项是必须要填的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=213, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44d08201428, createdName=ms7000001023316259, createdTime=Mon Jun 13 17:39:32 CST 2022, time=2022-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227148, encodeId=e940122e148b0, content=这个会进sci吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=225, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ac0d5397053, createdName=小月小月, createdTime=Sat Jun 18 07:12:01 CST 2022, time=2022-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226209, encodeId=fa6f12262097f, content=投稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=225, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44d08201428, createdName=ms7000001023316259, createdTime=Mon Jun 13 17:40:14 CST 2022, time=2022-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1110605, encodeId=fc751110605c1, content=RUNINGTITLE是必须的么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=398, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:54 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1073882, encodeId=bff110e388286, content=审稿速度:1.0 | 投稿命中率:25.0 | 版面费用:3500.0<br>偏重的研究方向:大数据;临床<br>经验分享:新刊,目前审稿很快,偏向临床大数据研究, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=495, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59955713944, createdName=ms7000001323288958, createdTime=Thu Nov 25 16:45:11 CST 2021, time=2021-11-25, status=1, ipAttribution=)]
    2022-06-13 ms7000001023316259

    Plagiarism check 投稿时这个选项是必须要填的吗

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=2170791, encodeId=729821e0791d1, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:心血管<br>经验分享:还没投,不知道, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24268459349, createdName=ms9000001322752373, createdTime=Fri Nov 24 17:12:52 CST 2023, time=2023-11-24, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2141847, encodeId=dbd8214184eb2, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:妇产科学;生育健康<br>经验分享:4.26 投稿<br>4.29 under review<br>中间状态变为 with editor, under review, required reviews completed,under review<br>5.28 required reviews completed,目前该持续近两周<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96ca8289510, createdName=ms8000000261515096, createdTime=Fri Jun 09 10:50:18 CST 2023, time=2023-06-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2100279, encodeId=80a121002e986, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:送审5-6位专家,意见给的都挺多,挺中肯。editor处理速度挺快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b5e3064566, createdName=3120102952, createdTime=Sun Nov 13 16:11:14 CST 2022, time=2022-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1110606, encodeId=fd2f11106067e, content=RUNNINGTITLE和TITLE的区别?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=491, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Mon Dec 27 14:52:54 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226206, encodeId=5cd51226206ca, content=Plagiarism check 投稿时这个选项是必须要填的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=213, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44d08201428, createdName=ms7000001023316259, createdTime=Mon Jun 13 17:39:32 CST 2022, time=2022-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227148, encodeId=e940122e148b0, content=这个会进sci吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=225, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ac0d5397053, createdName=小月小月, createdTime=Sat Jun 18 07:12:01 CST 2022, time=2022-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226209, encodeId=fa6f12262097f, content=投稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=225, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44d08201428, createdName=ms7000001023316259, createdTime=Mon Jun 13 17:40:14 CST 2022, time=2022-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1110605, encodeId=fc751110605c1, content=RUNINGTITLE是必须的么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=398, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:54 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1073882, encodeId=bff110e388286, content=审稿速度:1.0 | 投稿命中率:25.0 | 版面费用:3500.0<br>偏重的研究方向:大数据;临床<br>经验分享:新刊,目前审稿很快,偏向临床大数据研究, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=495, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59955713944, createdName=ms7000001323288958, createdTime=Thu Nov 25 16:45:11 CST 2021, time=2021-11-25, status=1, ipAttribution=)]
    2022-06-18 小月小月

    这个会进sci吗

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=2170791, encodeId=729821e0791d1, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:心血管<br>经验分享:还没投,不知道, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24268459349, createdName=ms9000001322752373, createdTime=Fri Nov 24 17:12:52 CST 2023, time=2023-11-24, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2141847, encodeId=dbd8214184eb2, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:妇产科学;生育健康<br>经验分享:4.26 投稿<br>4.29 under review<br>中间状态变为 with editor, under review, required reviews completed,under review<br>5.28 required reviews completed,目前该持续近两周<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96ca8289510, createdName=ms8000000261515096, createdTime=Fri Jun 09 10:50:18 CST 2023, time=2023-06-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2100279, encodeId=80a121002e986, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:送审5-6位专家,意见给的都挺多,挺中肯。editor处理速度挺快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b5e3064566, createdName=3120102952, createdTime=Sun Nov 13 16:11:14 CST 2022, time=2022-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1110606, encodeId=fd2f11106067e, content=RUNNINGTITLE和TITLE的区别?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=491, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Mon Dec 27 14:52:54 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226206, encodeId=5cd51226206ca, content=Plagiarism check 投稿时这个选项是必须要填的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=213, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44d08201428, createdName=ms7000001023316259, createdTime=Mon Jun 13 17:39:32 CST 2022, time=2022-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227148, encodeId=e940122e148b0, content=这个会进sci吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=225, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ac0d5397053, createdName=小月小月, createdTime=Sat Jun 18 07:12:01 CST 2022, time=2022-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226209, encodeId=fa6f12262097f, content=投稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=225, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44d08201428, createdName=ms7000001023316259, createdTime=Mon Jun 13 17:40:14 CST 2022, time=2022-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1110605, encodeId=fc751110605c1, content=RUNINGTITLE是必须的么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=398, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:54 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1073882, encodeId=bff110e388286, content=审稿速度:1.0 | 投稿命中率:25.0 | 版面费用:3500.0<br>偏重的研究方向:大数据;临床<br>经验分享:新刊,目前审稿很快,偏向临床大数据研究, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=495, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59955713944, createdName=ms7000001323288958, createdTime=Thu Nov 25 16:45:11 CST 2021, time=2021-11-25, status=1, ipAttribution=)]
    2022-06-13 ms7000001023316259

    投稿

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=2170791, encodeId=729821e0791d1, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:心血管<br>经验分享:还没投,不知道, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24268459349, createdName=ms9000001322752373, createdTime=Fri Nov 24 17:12:52 CST 2023, time=2023-11-24, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2141847, encodeId=dbd8214184eb2, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:妇产科学;生育健康<br>经验分享:4.26 投稿<br>4.29 under review<br>中间状态变为 with editor, under review, required reviews completed,under review<br>5.28 required reviews completed,目前该持续近两周<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96ca8289510, createdName=ms8000000261515096, createdTime=Fri Jun 09 10:50:18 CST 2023, time=2023-06-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2100279, encodeId=80a121002e986, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:送审5-6位专家,意见给的都挺多,挺中肯。editor处理速度挺快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b5e3064566, createdName=3120102952, createdTime=Sun Nov 13 16:11:14 CST 2022, time=2022-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1110606, encodeId=fd2f11106067e, content=RUNNINGTITLE和TITLE的区别?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=491, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Mon Dec 27 14:52:54 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226206, encodeId=5cd51226206ca, content=Plagiarism check 投稿时这个选项是必须要填的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=213, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44d08201428, createdName=ms7000001023316259, createdTime=Mon Jun 13 17:39:32 CST 2022, time=2022-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227148, encodeId=e940122e148b0, content=这个会进sci吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=225, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ac0d5397053, createdName=小月小月, createdTime=Sat Jun 18 07:12:01 CST 2022, time=2022-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226209, encodeId=fa6f12262097f, content=投稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=225, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44d08201428, createdName=ms7000001023316259, createdTime=Mon Jun 13 17:40:14 CST 2022, time=2022-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1110605, encodeId=fc751110605c1, content=RUNINGTITLE是必须的么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=398, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:54 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1073882, encodeId=bff110e388286, content=审稿速度:1.0 | 投稿命中率:25.0 | 版面费用:3500.0<br>偏重的研究方向:大数据;临床<br>经验分享:新刊,目前审稿很快,偏向临床大数据研究, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=495, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59955713944, createdName=ms7000001323288958, createdTime=Thu Nov 25 16:45:11 CST 2021, time=2021-11-25, status=1, ipAttribution=)]
    2021-12-29 桑晒麦拉

    RUNINGTITLE是必须的么?

    1

    展开1条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=2170791, encodeId=729821e0791d1, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:心血管<br>经验分享:还没投,不知道, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24268459349, createdName=ms9000001322752373, createdTime=Fri Nov 24 17:12:52 CST 2023, time=2023-11-24, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2141847, encodeId=dbd8214184eb2, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:妇产科学;生育健康<br>经验分享:4.26 投稿<br>4.29 under review<br>中间状态变为 with editor, under review, required reviews completed,under review<br>5.28 required reviews completed,目前该持续近两周<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96ca8289510, createdName=ms8000000261515096, createdTime=Fri Jun 09 10:50:18 CST 2023, time=2023-06-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2100279, encodeId=80a121002e986, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:送审5-6位专家,意见给的都挺多,挺中肯。editor处理速度挺快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b5e3064566, createdName=3120102952, createdTime=Sun Nov 13 16:11:14 CST 2022, time=2022-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1110606, encodeId=fd2f11106067e, content=RUNNINGTITLE和TITLE的区别?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=491, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Mon Dec 27 14:52:54 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226206, encodeId=5cd51226206ca, content=Plagiarism check 投稿时这个选项是必须要填的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=213, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44d08201428, createdName=ms7000001023316259, createdTime=Mon Jun 13 17:39:32 CST 2022, time=2022-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227148, encodeId=e940122e148b0, content=这个会进sci吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=225, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ac0d5397053, createdName=小月小月, createdTime=Sat Jun 18 07:12:01 CST 2022, time=2022-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226209, encodeId=fa6f12262097f, content=投稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=225, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44d08201428, createdName=ms7000001023316259, createdTime=Mon Jun 13 17:40:14 CST 2022, time=2022-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1110605, encodeId=fc751110605c1, content=RUNINGTITLE是必须的么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=398, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:54 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1073882, encodeId=bff110e388286, content=审稿速度:1.0 | 投稿命中率:25.0 | 版面费用:3500.0<br>偏重的研究方向:大数据;临床<br>经验分享:新刊,目前审稿很快,偏向临床大数据研究, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=495, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59955713944, createdName=ms7000001323288958, createdTime=Thu Nov 25 16:45:11 CST 2021, time=2021-11-25, status=1, ipAttribution=)]
    2021-11-25 ms7000001323288958

    审稿速度:1.0 | 投稿命中率:25.0 | 版面费用:3500.0
    偏重的研究方向:大数据;临床
    经验分享:新刊,目前审稿很快,偏向临床大数据研究

    1

    展开1条回复
共16条页码: 1/2页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分